NS

Narendra Singh

Active Director Director DIN 10051334
DIN 10051334 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Narendra Singh

Data last updated:

Narendra Singh is a Director at Cawnpore Med Hospital Private Limited (since 2024). The company operates in Healthcare. Cawnpore Med Hospital Private Limited reported revenue of ₹70.5 Lakh (FY 2025).

DIN 10051334
Primary Designation Director
Industry Healthcare
First Appointment 27 Mar 2024
Oldest Company Age 4 yrs
Largest company Cawnpore Med Hospital Private Limited · ₹70.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20242022₹70.5 Lakh (FY 2025)Active

Board colleagues of Narendra Singh

Directorship timeline

Open interactive timeline →
Cawnpore Med Hospital Private Limited
Premium access

Shareholding and investment profile for Narendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narendra Singh

Narendra Singh currently holds 1 directorship: Cawnpore Med Hospital Private Limited (Director, since 27 Mar 2024, revenue ₹70.5 Lakh (FY 2025)).

Narendra Singh was first appointed on 27 Mar 2024 as Director at Cawnpore Med Hospital Private Limited.

The current boards of Narendra Singh's companies include Kavita Katiyar (Cawnpore Med Hospital Private Limited), Rishabh Katiyar (Cawnpore Med Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available